AccessPak for HIV PEP Expanded with Kaletra and Novo-Clavamoxin 125
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Novo-Clavamoxin 125 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: amoxicillin / clavulanate
Brand name: Augmentin, Augmentin ES-600, Augmentin XR
Synonyms: Amoxicillin and Clavulanate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Novo-Clavamoxin 250
- AccessPak for HIV PEP Expanded with Kaletra-Novo-Furan Suspension
- AccessPak for HIV PEP Expanded with Kaletra-Novo-Hydrocort Cream Topical application
- AccessPak for HIV PEP Expanded with Kaletra-Novo-Hydrocort Topical application
- AccessPak for HIV PEP Expanded with Kaletra-Novo-Lexin
- AccessPak for HIV PEP Expanded with Kaletra-Novo-Methacin Suppositories
- Novo-Clavamoxin 125-AccessPak for HIV PEP Expanded with Viracept
- Novo-Clavamoxin 125-Accolate
- Novo-Clavamoxin 125-Accretropin
- Novo-Clavamoxin 125-Accucaine
- Novo-Clavamoxin 125-AccuHist Drops
- Novo-Clavamoxin 125-AccuHist PDX Drops